Publication | Closed Access
Treatment of Sarcopenia with Bimagrumab: Results from a Phase II, Randomized, Controlled, Proof‐of‐Concept Study
215
Citations
17
References
2017
Year
Treatment with bimagrumab over 16 weeks increased muscle mass and strength in older adults with sarcopenia and improved mobility in those with slow walking speed.
| Year | Citations | |
|---|---|---|
Page 1
Page 1